Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

External-application compound hemostatic analgesia anti-inflammation medicine

An anti-inflammatory drug and compound technology, applied in the field of external compound drugs, can solve the problems of susceptibility to infection, slow blood coagulation and hemostasis, inconvenient use, etc., and achieve the effects of convenient portability and use, remarkable hemostasis effect, and simple and easy operation.

Inactive Publication Date: 2005-12-21
肖春
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, commonly used wound hemostatic drugs include Baiyao, thrombin, etc. These drugs can only be used for hemostasis and coagulation of small wounds, but they are not effective for sudden larger wounds. The main manifestations are: slow coagulation and hemostasis, and easy infection , unable to relieve pain, inconvenient to use, especially in harsh environments such as battlefields and fields, because the wound is prone to suppuration and infection, it cannot effectively exert its hemostatic effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] An external compound hemostatic analgesic and anti-inflammatory spray is characterized in that it is formulated from the following main ingredients and auxiliary materials in parts by weight:

[0025] Hemostatic agent A: 0.05~2

[0026] Vasoconstrictor B: 0.005~0.02

[0027] Anesthetic C: 0.5~3.0

[0028] Antibacterial drug D: 0.1~5

[0029] Solvent: 5~70

[0030] The hemostatic agent A is Batroxella; the vasoconstrictor B is norepinephrine; the anesthetic C is lidocaine; the antibacterial drug D is ofloxacin; and the solvent is water.

[0031] The preparation process of the spray is as follows:

[0032] Take the hemostatic agent A, vasoconstrictor B, anesthetic agent C and antibacterial agent D of the above weight parts in 500mml solvent, fully stir, make dissolving, adjust pH to 6-8, filter, add water to 1000ml, mix well, pour into 50mml plastic spray bottle, 300 sprays per bottle.

Embodiment 2

[0034] An external compound hemostatic analgesic and anti-inflammatory spray is characterized in that it is formulated from the following main ingredients and auxiliary materials in parts by weight:

[0035] Hemostatic agent A: 0.05~2

[0036] Vasoconstrictor B: 0.005~0.02

[0037] Anesthetic C: 1.2~2.0

[0038] Antibacterial drug D: 0.1~5

[0039] Solvent: 5~70

[0040] The hemostatic agent A is thrombin; the vasoconstrictor B is norepinephrine; the anesthetic C is carbocaine; the antibacterial drug D is neomycin sulfate; and the solvent is ethanol.

[0041] The preparation process of the spray is as follows:

[0042] Take the hemostatic agent A, vasoconstrictor B, anesthetic C and antibacterial drug D of the above weight parts in 500ml solvent, fully stir to dissolve, and adjust the pH to 6-8, filter, add ethanol to 1000ml, mix well, pot and seal in 50ml plastic spray bottle, 300 sprays per bottle.

Embodiment 3

[0044] An external compound hemostatic analgesic and anti-inflammatory spray is characterized in that it is formulated from the following main ingredients and auxiliary materials in parts by weight:

[0045] Hemostatic agent A: 0.05~5

[0046] Vasoconstrictor B: 0.005~0.02

[0047] Anesthetic C: 0.6~1.0

[0048] Antibacterial drug D: 0.1~5

[0049] Solvent: 5~70

[0050] The hemostatic agent A is Antenoxin; the vasoconstrictor B is norepinephrine; the anesthetic C is dyclonine; the antibacterial drug D is levofloxacin; the solvent is water.

[0051] The preparation process of the spray is as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a compound hemostatic analgesic anti-inflammatory medicine for external application. It is made up by using (by weight portion) 0.05-5 portions of hemostatic, 0.005-0.02 portion of vasoconstrictor, 0.5-3.0 portions of narcotic and 0.1-5 portions of antimicrobial medicine. At the same time it can be made into various preparations for external application, including spray and powder for external application.

Description

technical field [0001] The invention relates to a compound externally-used hemostatic drug, in particular, the invention relates to an externally-applied compound drug which has analgesic and anti-inflammatory effects while stopping bleeding. Background technique [0002] At present, commonly used wound hemostatic drugs include Baiyao, thrombin, etc. These drugs can only be used for hemostasis and coagulation of small wounds, but they are not effective for sudden larger wounds. The main manifestations are: slow coagulation and hemostasis, and easy infection , can't alleviate the pain, inconvenient to use, especially in harsh environments such as battlefields and fields, because the wound is easy to suppurate and infect, it can't effectively exert its hemostatic effect. Contents of the invention [0003] The object of the present invention is to overcome the above-mentioned defects of external hemostatic drugs, and provide an external compound hemostatic drug which can stop...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K45/00
Inventor 杨俊毅
Owner 肖春
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com